Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
01/1997
01/09/1997CA2225277A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders
01/08/1997EP0751932A1 Vitamin-d amide derivatives
01/08/1997EP0469075B1 Use of lipoxin a 4? and its derivatives as antagonists for slow-reacting substances of anaphylaxis
01/08/1997CN1139928A Novel compound
01/08/1997CN1139917A Calcium receptor-active arylalkyl amines
01/08/1997CN1139567A Chinese proprietary medicine for protrusion of intervertebral disc
01/08/1997CN1033750C Intermediates useful in the production of aromatic amino-alcohol derivatives having antidiabetes and antiobesity properties
01/07/1997US5591753 Combination treatment for osteoporosis
01/02/1997EP0750743A1 Methods and devices for automatic assessment of corn
01/02/1997EP0750502A1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies
12/1996
12/31/1996US5589514 Arylcycloalkyl derivatives, their production and their use
12/31/1996US5589482 Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
12/31/1996US5589458 Compounds that inhibit T cell proliferation and methods for using the same
12/31/1996US5589452 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/27/1996WO1996041618A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions
12/27/1996CA2223568A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions
12/19/1996WO1996040909A1 Bone stimulating factor
12/19/1996WO1996040903A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996WO1996040681A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
12/19/1996WO1996040636A1 Catechol diethers derivatives useful as pharmaceutical agents
12/19/1996WO1996040193A1 CYCLIC ANALOGS OF PTH AND PTHrP
12/19/1996WO1996040143A1 Imidazole compounds
12/19/1996CA2223940A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996CA2223533A1 Imidazole compounds
12/19/1996CA2222789A1 Bone stimulating factor
12/18/1996EP0748320A1 Prodrugs of morpholine tachykinin receptor antagonists
12/18/1996EP0748313A1 Cytokine inhibiting imidazole substituted hydroxamic acid derivatives
12/18/1996CN1138350A CNTF Family antagonists
12/18/1996CN1138037A Adhesion receptor antagonists
12/18/1996CN1137912A Tongyangqing for curing pain and itch
12/17/1996US5585356 Matrix metalloproteinase peptides: role in diagnosis and therapy
12/17/1996US5585089 Humanized immunoglobulins
12/12/1996WO1996039408A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
12/12/1996WO1996039196A1 Gene transfer for treating a connective tissue of a mammalian host
12/12/1996WO1996039169A1 Methods and compositions for healing and repair of connective tissue attachment
12/12/1996WO1996039149A1 Anhydrous alendronate monosodium salt formulations
12/12/1996WO1996039134A1 Osteogenetic promoting pharmaceutical composition
12/12/1996CA2562162A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2224176A1 Gene transfer for treating a connective tissue of a mammalian host
12/12/1996CA2221784A1 Osteogenetic promoting pharmaceutical composition
12/11/1996EP0747380A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747377A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747376A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747353A2 Indole derivatives
12/11/1996EP0746324A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds
12/11/1996CN1137525A Naphthyl compounds, intermediates, compositions, and methods
12/11/1996CN1137407A Quick-acting Duangusan powder capable of setting of fracture in 2-6 hours
12/11/1996CN1137396A Spur pain-removing plaster
12/11/1996CN1137386A Dieda Huoxuesan powder for curing fracture and injury
12/08/1996CA2178184A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178183A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178182A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/05/1996WO1996038471A1 Dipeptides which promote release of growth hormone
12/05/1996WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996WO1996038167A1 Use of fibroblast growth factors to stimulate bone growth
12/05/1996WO1996038156A1 Use of alendronate for the prevention of osteoporosis
12/05/1996CA2222318A1 Use of alendronate for the prevention of osteoporosis
12/05/1996CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/04/1996EP0745136A1 B7-1-specific ligands, and their use for the induction of t cell anergy
12/04/1996EP0745094A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
12/04/1996EP0440738B1 Treatment of hypertension
12/04/1996CN1136920A Use of benzopyran derivatives for production of pharmaceutical compositions
12/03/1996US5580985 Substituted pyrazoles for the treatment of inflammation
12/03/1996US5580865 2,2-disubstituted cephem sulphones
11/1996
11/27/1996EP0744176A2 Methods for inhibiting bone loss
11/26/1996US5578708 Derived from bones of mammals including mice and humans; diagnosis and therapy for bone metabolic diseases
11/26/1996US5578612 Indole derivatives
11/26/1996US5578569 Method of increasing bone growth
11/24/1996CA2177115A1 Methods for inhibiting bone loss
11/21/1996WO1996036642A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996WO1996036617A1 Substituted oxazoles for the treatment of inflammation
11/21/1996CA2221692A1 Substituted oxazoles for the treatment of inflammation
11/21/1996CA2219487A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/20/1996CN1136278A Combination of bisphosphonates and growth hormone secretagogues
11/19/1996US5576438 Lipoxygenase inhibitors; antiallergens, antiinflammatory agents
11/19/1996US5576340 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses
11/14/1996WO1996035447A1 Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours
11/14/1996WO1996035422A1 Methods for inhibiting bone loss
11/14/1996DE19517430A1 Pharmazeutische Darreichungsform von Parathormon mit einer zwei- bis sechsstündigen Wirkstoff-Freisetzungsperiode The pharmaceutical dosage form of parathyroid hormone with a two- to six-hour drug release period
11/14/1996CA2220034A1 Methods for inhibiting bone loss
11/13/1996EP0742203A2 Vitamin D compounds and method of preparing these compounds
11/13/1996EP0742013A1 Stable liquid composition containing urate oxidase and lyophilized composition for its preparation
11/13/1996EP0742010A2 Benzoquinolin-3-ones to inhibit bone loss
11/13/1996EP0741785A1 Methods and compositions for stimulating bone cells
11/13/1996EP0741784A1 Ligand (act-4-l) to a receptor on the surface of activated cd4?+ t-cells
11/13/1996EP0741578A1 Human growth hormone
11/13/1996CN1135771A DNA sequence coding for a BMP receptor
11/12/1996US5574190 Naphthyl compounds, intermediates, compositions, and methods
11/12/1996CA2068438C Essential pure human parathyroid hormone
11/10/1996CA2175881A1 Vitamin d compounds and methods of preparing these compounds
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/06/1996EP0741133A2 Adhesion receptor antagonists
11/06/1996EP0740936A2 Use of benzopyran derivatives for the manufacture of medicaments for the treatment of diseases connected with the sodium independent Cl-/HCO3- exchanger
11/06/1996CN1135176A Combination of progresterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for perio-and post menopausal women
11/06/1996CA2175747A1 Benzopyrane derivatives used for preparing pharmaceutical compositions used in the treatment of pathology related to na+ independent cl-/hco3- exchanger
11/05/1996US5571808 Substituted 2-aryl-3-aroylbenzo(b)thiophenes
11/05/1996US5571802 Method of treating post menopausal osteoporosis with hexafluro-vitamin D
10/1996
10/31/1996WO1996034104A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
10/31/1996CA2216931A1 Inhibiting photodecomposition of 3-substituted-2-oxindoles
1 ... 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 ... 820